GSK plc (GLAXF)
OTCMKTS
· Delayed Price · Currency is USD
16.01
-0.70 (-4.19%)
Jan 14, 2025, 11:03 AM EST
GSK plc Revenue
GSK plc had revenue of 8.01B GBP in the quarter ending September 30, 2024, a decrease of -1.66%. This brings the company's revenue in the last twelve months to 31.31B, up 5.59% year-over-year. In the year 2023, GSK plc had annual revenue of 30.33B with 3.42% growth.
Revenue (ttm)
31.31B GBP
Revenue Growth
+5.59%
P/S Ratio
n/a
Revenue / Employee
445.95K GBP
Employees
70,212
Market Cap
64.36B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
Jun An Kang Group | 4.47M |
GSK plc News
- 4 days ago - Why CureVac (CVAC) Shares Are Volatile - Benzinga
- 5 days ago - Why Novavax Stock Is Volatile This Week - Benzinga
- 6 days ago - GSK Nears $1 Billion Deal for Biotech Company IDRx - BNN Bloomberg
- 6 days ago - Why CureVac (CVAC) Stock Is Moving - Benzinga
- 6 days ago - GSK is said to be nearing $1B deal to acquire U.S. biotech IDRx - Seeking Alpha
- 6 days ago - GSK nears $1bn deal for biotech developing drug for rare tumour - Financial Times
- 6 days ago - Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder - Benzinga
- 6 days ago - Wave Life Sciences Is A Buy On Pipeline Prospects - Seeking Alpha